Dr. Patrick Boyle, MD

NPI: 1184630816
Total Payments
$81,460
2021 Payments
$39.45
Companies
4
Transactions
100

Payment Breakdown by Category

Other$74,410 (91.3%)
Travel$4,940 (6.1%)
Food & Beverage$2,077 (2.5%)
Education$32.40 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $74,410 29 91.3%
Travel and Lodging $4,940 25 6.1%
Food and Beverage $2,077 44 2.5%
Education $32.40 2 0.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $60,793 79 $0 (2021)
Novo Nordisk Inc $20,629 19 $0 (2019)
Janssen Pharmaceuticals, Inc $19.41 1 $0 (2018)
ZS Pharma. Inc. $18.98 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2021 $39.45 1 AstraZeneca Pharmaceuticals LP ($39.45)
2020 $27.41 1 AstraZeneca Pharmaceuticals LP ($27.41)
2019 $170.29 3 Novo Nordisk Inc ($105.06)
2018 $7,142 21 AstraZeneca Pharmaceuticals LP ($7,122)
2017 $74,081 74 AstraZeneca Pharmaceuticals LP ($53,538)

All Payment Transactions

100 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
06/22/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $39.45 General
01/16/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $27.41 General
Category: Cardiovascular and Metabolism
09/25/2019 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $31.98 General
04/16/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $105.06 General
Category: Diabetes
04/12/2019 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $33.25 General
12/13/2018 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $35.63 General
11/08/2018 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $11.34 General
09/07/2018 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $44.50 General
08/23/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Education In-kind items and services $5.40 General
Category: Cardiovascular and Metabolism
08/03/2018 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Education In-kind items and services $27.00 General
Category: Cardiovascular and Metabolism
08/01/2018 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $32.00 General
06/27/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.47 General
Category: Cardiovascular and Metabolism
05/06/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $100.00 General
Category: Cardiovascular and Metabolism
03/22/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,750.00 General
Category: Cardiovascular and Metabolism
03/06/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Travel and Lodging In-kind items and services $80.66 General
Category: Cardiovascular and Metabolism
03/06/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $21.68 General
Category: Cardiovascular and Metabolism
02/07/2018 Janssen Pharmaceuticals, Inc INVOKANA (Drug), INVOKAMET, XARELTO Food and Beverage In-kind items and services $19.41 General
Category: Cardiovascular & Metabolism
02/06/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: Cardiovascular and Metabolism
01/20/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Travel and Lodging In-kind items and services $509.58 General
Category: Cardiovascular and Metabolism
01/20/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Travel and Lodging In-kind items and services $174.58 General
Category: Cardiovascular and Metabolism
01/20/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism
01/20/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Travel and Lodging In-kind items and services $74.70 General
Category: Cardiovascular and Metabolism
01/20/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $46.12 General
Category: Cardiovascular and Metabolism
01/20/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $32.18 General
Category: Cardiovascular and Metabolism
01/20/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $23.54 General
Category: Cardiovascular and Metabolism

About Dr. Patrick Boyle, MD

Dr. Patrick Boyle, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Depoe Bay, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184630816.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Boyle, MD has received a total of $81,460 in payments from pharmaceutical and medical device companies, with $39.45 received in 2021. These payments were reported across 100 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,410).

Practice Information

  • Specialty Endocrinology, Diabetes & Metabolism
  • Other Specialties Diabetes & Metabolism
  • Location Depoe Bay, OR
  • Active Since 08/01/2006
  • Last Updated 08/11/2011
  • Taxonomy Code 207RE0101X
  • Entity Type Individual
  • NPI Number 1184630816

Products in Payments

  • FARXIGA (Drug) $51,205
  • Tresiba (Drug) $14,052
  • BYDUREON (Drug) $9,236
  • Victoza (Drug) $2,670
  • Xultophy 100/3.6 (Drug) $2,661
  • Xultophy (Drug) $360.00
  • Ozempic (Drug) $105.06
  • LOKELMA (Drug) $54.41
  • BYDUREON DCP (Drug) $33.00
  • INVOKANA (Drug) $19.41
  • ONGLYZA (Drug) $16.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.